Kbc Group Nv Phibro Animal Health Corp Transaction History

Kbc Group Nv

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Feb 15, 2024	BUY	$12.82 - $20.22 $20,153 - $31,785	1,572 New	1,572 $21,000
Q2 2022 Feb 14, 2024	BUY	$17.89 - $20.47 $28,123 - $32,178	1,572 New	1,572 $30,000
Q2 2022 Jul 26, 2022	SELL	$17.89 - $20.47 $50,217 - $57,459	-2,807 Reduced 64.1%	1,572 $30,000
Q4 2018 Jan 31, 2019	SELL	$31.18 - $44.64 $364,275 - $521,529	-11,683 Reduced 72.74%	4,379 $140,000
Q3 2018 Nov 14, 2018	BUY	$42.3 - $53.5 $490,003 - $619,744	11,584 Added 258.69%	16,062 $0
Q3 2017 Nov 13, 2017	BUY	$35.0 - $40.0 $156,730 - $179,120	4,478	4,478 $0

148

20.5M

Ticker PAHC
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 20,337,600
Market Cap $497M
Description
Phibro Animal Health Corporation develops, manufactures, and supplies a range of animal health and mineral nutrition products for food and companion animals. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets products for poultry, swine, beef and dairy c...

Get notified when there are updates to the investment portfolio of Kbc Group Nv, based on Form 13F filings with the SEC.

Stay updated on Kbc Group Nv with notifications on news.